Cover Image

Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines?

Saved in:

Bibliographic Details
Main Author:	Melody Okereke (Author)
Format:	Book
Published:	Elsevier, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Transparency in Negotiation of European Union With Big Pharma on COVID-19 Vaccines
by: Salvatore Sciacchitano, et al.
Published: (2021)

Holding big Pharma Accountable
by: Richard M Fleming1, et al.
Published: (2019)

Vaccine Inequities, Intellectual Property Rights and Pathologies of Power in the Global Response to COVID-19
by: Eivind Engebretsen, et al.
Published: (2022)

Intellectual Property Rights
Published: (2017)

Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars
by: Niazi S
Published: (2022)

Waived Consent in Perinatal/Neonatal Research-When Is It Appropriate?
by: Wade D. Rich, et al.
Published: (2019)

The professional Guinea pig: big pharma and the risky world of human subjects
by: Orenzio Soler
Published: (2011)

The professional Guinea pig: big pharma and the risky world of human subjects
by: Orenzio Soler
Published: (2011)

COVID-19 vaccine equity and the right to health for displaced Venezuelans in Latin America
by: David C. Hill, et al.
Published: (2023)

COVID-19 vaccine equity and the right to health for displaced Venezuelans in Latin America.
by: David C Hill, et al.
Published: (2023)

Intellectual Property Rights Patent
Published: (2020)

Lobbying by Big Pharma, bottlenecks for clinical research, and loosening of ethical standards in Brazil
by: Francisco José Roma Paumgartten
Published: (2016)

BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management
by: Victor G. Rodwin, et al.
Published: (2018)

An Evaluation of Local Pharmaceutical Manufacturing in Zimbabwe: How Prepared is Zimbabwe to Produce COVID-19 Vaccines?
by: Melody Okereke, et al.
Published: (2022)

Health and intellectual property rights
by: Carlos M. Correa

Waiving the consent requirement to mitigate bias in observational precision medicine research
by: Ruifeng Song
Published: (2024)

COVID-19 vaccine equity in the Americas
by: The Lancet Regional Health- Americas
Published: (2022)

The Cultural Production of Intellectual Property Rights
by: Johnson Andrews, Sean
Published: (2019)

The Cultural Production of Intellectual Property Rights
by: Johnson Andrews, Sean
Published: (2019)

Who should be prioritised for COVID-19 vaccination?
by: Fiona M Russell, et al.
Published: (2021)

Business as Usual? Centering Human Rights to Advance Global COVID-19 Vaccine Equity Through COVAX
by: Kaitlin Fajber
Published: (2020)

Glocal Pharma
by: Johnson, Ericka
Published: (2016)

Glocal Pharma
by: Johnson, Ericka
Published: (2016)

Vaccine equity implementation: exploring factors influencing COVID-19 vaccine delivery in the Philippines from an equity lens
by: Junqiang Zhao, et al.
Published: (2024)

The implications of waiving local clinical trials for drugs in India: a double-edged sword?
by: Rajmohan Seetharaman
Published: (2024)

Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?
by: Zied Ben Chaouch, et al.
Published: (2022)

Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?
by: Zied Ben Chaouch, et al.
Published: (2022)

Vaccine equity or health equity?
by: David Bell, et al.
Published: (2022)

Measuring and Promoting SARS-CoV-2 Vaccine Equity: Development of a COVID-19 Vaccine Equity Index
Published: (2021)

Intellectual property rights: An overview and implications in pharmaceutical industry
by: Chandra Nath Saha, et al.
Published: (2011)

COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
by: Siti Setiati, et al.
Published: (2021)

PharmaCare 2018
by: Salvatore Riegler
Published: (2020)

Ability of community pharmacists to independently perform CLIA-waived testing - A multistate legal review
by: Joseph Doucette, et al.
Published: (2021)

Dos palabras más sobre ensayos clínicos: engaño/verdad, la anemia moral de la "Big Pharma"
by: Marvin Gómez-Vargas
Published: (2011)

COVID-19: should oral vaccination strategies be given more consideration?
by: Aman Mehan, et al.
Published: (2020)

Getting access to the COVID-19 vaccine: What should be our approach?
by: Subodh Kumar, et al.
Published: (2021)

Assessing barriers to access and equity for COVID-19 vaccination in the US
by: Michael Kuehn, et al.
Published: (2022)

Intellectual property rights protection,Rival's asymmetry and differentiated products
by: Wasin Rojayaroon
Published: (2015)

Public health, innovation and intellectual property rights: unfinished business
by: Tomris Türmen, et al.

Pandemics, intellectual property and 'our economy': A worldview analysis of Canada's role in compromising global access to COVID-19 vaccines
by: Ben Brisbois, et al.
Published: (2024)